E-santé
Il y a 1 mois
We Are Patients lance des Live Facebook

La média patient We Are Patients lance les premiers Facebook Live de la santé qui donnent la parole aux patients engagés, dans un format intimiste et interactif. Découverte. We Are…

Cet article We Are Patients lance des Live Facebook est apparu en premier sur Buzz-esanté.

Buzz esante
Articles liés par le même flux
Presse médicale
Il y a 1 heures
ScienceDirect

Publication date: Available online 23 May 2017
Source:Médecine et Maladies Infectieuses
Author(s): P.A. Coffie, A. Patassi, A. Doumbia, G. Bado, E. Messou, A. Minga, E. Allah-Kouadio, D.M. Zannou, M. Seydi, A.R. Kakou, F. Dabis, G. Wandeler
BackgroundWe aimed to describe changes in hepatitis B screening practices over a 3-year period among HIV-infected patients in West Africa.MethodsA medical chart review was conducted in urban HIV treatment centers in Ivory Coast (3 sites), Benin, Burkina Faso, Senegal, and Togo (1 site each). Among patients who started antiretroviral treatment between 2010 and 2012, 100 per year were randomly selected from each clinic. Demographic, clinical, and laboratory data was collected using a standardized questionnaire. We assessed changes in the proportion of patients screened over time and identified predictors of screening in a multivariable logistic regression.ResultsA total of 2097 patients were included (median age: 37 years, 65.4% of women). Overall, 313 (14.9%) patients had been screened for hepatitis B, with an increase from 10.6% in 2010 to 18.9% in 2012 (P0.001) and substantial differences across countries. In multivariable analysis, being aged over 45 years (adjusted odds ratio: 1.34 [1.01–1.77]) and having an income-generating activity (adjusted odds ratio: 1.82 [1.09–3.03]) were associated with screening for hepatitis B infection. Overall, 62 HIV-infected patients (19.8%, 95% confidence interval: 15.5–24.7) were HBsAg-positive and 82.3% of them received a tenofovir-co[...]

Presse médicale
Il y a 1 heures
ScienceDirect

Publication date: Available online 27 April 2017
Source:Annales d'Endocrinologie
Author(s): Albert Beckers, Liliya Rostomyan, Iulia Potorac, Pablo Beckers, Adrian F. Daly
X-linked acrogigantism (XLAG) is a new, pediatric-onset genetic syndrome, due to Xq26.3 microduplications encompassing the GPR101 gene. XLAG has a remarkably distinct phenotype with disease onset occurring before the age of 5 in all cases described to date, which is significantly younger than in other forms of pituitary gigantism. These patients have mixed GH and prolactin positive adenomas and/or mixed-cell hyperplasia and highly elevated levels of GH/IGF-1 and prolactin. Given their particularly young age of onset, the[...]

Presse médicale
Il y a 1 heures
ScienceDirect

Publication date: Available online 5 May 2017
Source:Annales d'Endocrinologie
Author(s): Liliya Rostomyan, Iulia Potorac, Pablo Beckers, Adrian F. Daly, Albert Beckers
AIP mutations are rare in sporadic acromegaly but they are seen at a higher frequency among certain specific populations of pituitary adenoma patients (pituitary gigantism cases, familial isolated pituitary adenoma (FIPA) kindreds, and patients with macroadenomas who are diagnosed ≤30 years). AIP mutations are most prevalent in patients with pituitary gigantism (29% of this group were found to have mutations in AIP gene). These data support targeted genetic screening for AIP mutations/deletions in these groups of pituitary [...]

Presse médicale
Il y a 1 heures
ScienceDirect

Publication date: Available online 4 May 2017
Source:Annales d'Endocrinologie
Author(s): Maïthé Tauber
Approximately 10% of small for gestational age (SGA) children maintain a small body size throughout childhood and often into adult life with a decreased pubertal spurt. Growth hormone (GH) therapy increases short-term growth in a dose–dependent manner and adult height had now been well documented. Shorter children might benefit from a higher dose at start (50μg/kg/day). The response to GH treatment was similar for both preterm and term short SGA groups and the effect of GH treatment on adult height showed a wide variation in growth response. As a whole, mean adult height is higher than −[...]

Presse médicale
Il y a 1 heures
ScienceDirect

Publication date: Available online 5 May 2017
Source:Annales d'Endocrinologie
Author(s): Thierry Brue, Alexandru Saveanu, Nicolas Jullien, Teddy Fauquier, Frédéric Castinetti, Alain Enjalbert, Anne Barlier, Rachel Reynaud
Through the multicentric international GENHYPOPIT network, 10 transcription factor genes involved in pituitary development have been screened in more than 1200 patients with constitutional hypopituitarism over the past two decades. The present report summarizes the main lessons learned from this phenotype-based genetic screening: (1) genetically determined hypopituitarism does not necessarily present during childhood; (2) constitutional hypopituitarism may be characterized by a pure endocrin[...]

Presse médicale
Il y a 1 heures
ScienceDirect

Publication date: Available online 8 May 2017
Source:Annales d'Endocrinologie
Author(s): Agnès Linglart, Valérie Merzoug, Anne-Sophie Lambert, Catherine Adamsbaum
Bone dysplasia is a large group that encompasses 436 rare diseases. Many of them are characterized by short stature or decreased growth velocity during puberty. The diagnosis of short stature due to skeletal dysplasia relies on (i) physical features such as disproportionate trunk/limbs, short limbs or extremities and/or stocky build, (ii) radiographic features to analyze mineralization, maturation and bone morphology, and (iii) whenever possible, the genetic characterization. Bone dysplasia mostly affect many organs, and therefo[...]